title: Regulatory T cells in cancer; can they be controlled?
authors: Medical Oncology Division, Dana Farber Cancer Institute, Harvard Medical School, 450 Brookline Avenue, Boston, MA 02215, USA.
authors: Dennis O
authors: DO
authors: Adeegbe
authors: Division of Cancer Immunology, Exploratory Oncology Research & Clinical Trial Center, National Cancer Center, Chiba 277-8577, Japan.
authors: Hiroyoshi
authors: H
authors: Nishikawa
mesh_terms: D014408:Biomarkers, Tumor / Q000276:immunology / Q000378:metabolism; D016207:Cytokines / Q000276:immunology / Q000378:metabolism; D006801:Humans; D008213:Lymphocyte Activation / Q000276:immunology; D016246:Lymphocytes, Tumor-Infiltrating / Q000276:immunology / Q000378:metabolism; D009369:Neoplasms / Q000276:immunology* / Q000378:metabolism; D013601:T-Lymphocytes / Q000276:immunology* / Q000378:metabolism; D050378:T-Lymphocytes, Regulatory / Q000276:immunology* / Q000378:metabolism; D059016:Tumor Microenvironment / Q000276:immunology*
chemical_list: D014408:Biomarkers, Tumor; D016207:Cytokines
keywords: TCR diversity; cancer; chemokines; function; immune checkpoint; immunotherapy; microenvironment; recruitment; regulatory T cell; tumor-associated antigen